The Fight against Infection and Pain: Devil’s Claw (<i>Harpagophytum procumbens</i>) a Rich Source of Anti-Inflammatory Activity: 2011–2022

<i>Harpagophytum procumbens</i> subsp. <i>procumbens</i> (Burch.) DC. ex Meisn. (Sesame seed Family—Pedaliaceae) is a popular medicinal plant known as Devil’s claw. It is predominantly distributed widely over southern Africa. Its impressive reputation is embedded in its tradi...

Full description

Bibliographic Details
Main Authors: Nomagugu Gxaba, Madira Coutlyne Manganyi
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/11/3637
_version_ 1827664530038063104
author Nomagugu Gxaba
Madira Coutlyne Manganyi
author_facet Nomagugu Gxaba
Madira Coutlyne Manganyi
author_sort Nomagugu Gxaba
collection DOAJ
description <i>Harpagophytum procumbens</i> subsp. <i>procumbens</i> (Burch.) DC. ex Meisn. (Sesame seed Family—Pedaliaceae) is a popular medicinal plant known as Devil’s claw. It is predominantly distributed widely over southern Africa. Its impressive reputation is embedded in its traditional uses as an indigenous herbal plant for the treatment of menstrual problems, bitter tonic, inflammation febrifuge, syphilis or even loss of appetite. A number of bioactive compounds such as terpenoids, iridoid glycosides, glycosides, and acetylated phenolic compounds have been isolated. Harpagoside and harpagide, iridoid glycosides bioactive compounds have been reported in countless phytochemical studies as potential anti-inflammatory agents as well as pain relievers. In-depth studies have associated chronic inflammation with various diseases, such as Alzheimer’s disease, obesity, rheumatoid arthritis, type 2 diabetes, cancer, and cardiovascular and pulmonary diseases. In addition, 60% of chronic disorder fatalities are due to chronic inflammatory diseases worldwide. Inflammation and pain-related disorders have attracted significant attention as leading causes of global health challenges. Articles published from 2011 to the present were obtained and reviewed in-depth to determine valuable data findings as well as knowledge gaps. Various globally recognized scientific search engines/databases including Scopus, PubMed, Google Scholar, Web of Science, and ScienceDirect were utilized to collect information and deliver evidence. Based on the literature results, there was a dramatic decrease in the number of studies conducted on the anti-inflammatory and analgesic activity of Devil’s claw, thereby presenting a potential research gap. It is also evident that currently in vivo clinical studies are needed to validate the prior massive in vitro studies, therefore delivering an ideal anti-inflammatory and analgesic agent in the form of <i>H. procumbens</i> products.
first_indexed 2024-03-10T01:02:15Z
format Article
id doaj.art-1a7ef0c986d54d68a4b9a860ea207fb0
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T01:02:15Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-1a7ef0c986d54d68a4b9a860ea207fb02023-11-23T14:32:01ZengMDPI AGMolecules1420-30492022-06-012711363710.3390/molecules27113637The Fight against Infection and Pain: Devil’s Claw (<i>Harpagophytum procumbens</i>) a Rich Source of Anti-Inflammatory Activity: 2011–2022Nomagugu Gxaba0Madira Coutlyne Manganyi1Department of Biological and Environmental Sciences, Faculty of Natural Sciences, Walter Sisulu University, PBX1, Mthatha 5117, South AfricaDepartment of Biological and Environmental Sciences, Faculty of Natural Sciences, Walter Sisulu University, PBX1, Mthatha 5117, South Africa<i>Harpagophytum procumbens</i> subsp. <i>procumbens</i> (Burch.) DC. ex Meisn. (Sesame seed Family—Pedaliaceae) is a popular medicinal plant known as Devil’s claw. It is predominantly distributed widely over southern Africa. Its impressive reputation is embedded in its traditional uses as an indigenous herbal plant for the treatment of menstrual problems, bitter tonic, inflammation febrifuge, syphilis or even loss of appetite. A number of bioactive compounds such as terpenoids, iridoid glycosides, glycosides, and acetylated phenolic compounds have been isolated. Harpagoside and harpagide, iridoid glycosides bioactive compounds have been reported in countless phytochemical studies as potential anti-inflammatory agents as well as pain relievers. In-depth studies have associated chronic inflammation with various diseases, such as Alzheimer’s disease, obesity, rheumatoid arthritis, type 2 diabetes, cancer, and cardiovascular and pulmonary diseases. In addition, 60% of chronic disorder fatalities are due to chronic inflammatory diseases worldwide. Inflammation and pain-related disorders have attracted significant attention as leading causes of global health challenges. Articles published from 2011 to the present were obtained and reviewed in-depth to determine valuable data findings as well as knowledge gaps. Various globally recognized scientific search engines/databases including Scopus, PubMed, Google Scholar, Web of Science, and ScienceDirect were utilized to collect information and deliver evidence. Based on the literature results, there was a dramatic decrease in the number of studies conducted on the anti-inflammatory and analgesic activity of Devil’s claw, thereby presenting a potential research gap. It is also evident that currently in vivo clinical studies are needed to validate the prior massive in vitro studies, therefore delivering an ideal anti-inflammatory and analgesic agent in the form of <i>H. procumbens</i> products.https://www.mdpi.com/1420-3049/27/11/3637Devil’s claw<i>Harpagophytum procumbens</i>clinical studiesanti-inflammatoryanalgesic
spellingShingle Nomagugu Gxaba
Madira Coutlyne Manganyi
The Fight against Infection and Pain: Devil’s Claw (<i>Harpagophytum procumbens</i>) a Rich Source of Anti-Inflammatory Activity: 2011–2022
Molecules
Devil’s claw
<i>Harpagophytum procumbens</i>
clinical studies
anti-inflammatory
analgesic
title The Fight against Infection and Pain: Devil’s Claw (<i>Harpagophytum procumbens</i>) a Rich Source of Anti-Inflammatory Activity: 2011–2022
title_full The Fight against Infection and Pain: Devil’s Claw (<i>Harpagophytum procumbens</i>) a Rich Source of Anti-Inflammatory Activity: 2011–2022
title_fullStr The Fight against Infection and Pain: Devil’s Claw (<i>Harpagophytum procumbens</i>) a Rich Source of Anti-Inflammatory Activity: 2011–2022
title_full_unstemmed The Fight against Infection and Pain: Devil’s Claw (<i>Harpagophytum procumbens</i>) a Rich Source of Anti-Inflammatory Activity: 2011–2022
title_short The Fight against Infection and Pain: Devil’s Claw (<i>Harpagophytum procumbens</i>) a Rich Source of Anti-Inflammatory Activity: 2011–2022
title_sort fight against infection and pain devil s claw i harpagophytum procumbens i a rich source of anti inflammatory activity 2011 2022
topic Devil’s claw
<i>Harpagophytum procumbens</i>
clinical studies
anti-inflammatory
analgesic
url https://www.mdpi.com/1420-3049/27/11/3637
work_keys_str_mv AT nomagugugxaba thefightagainstinfectionandpaindevilsclawiharpagophytumprocumbensiarichsourceofantiinflammatoryactivity20112022
AT madiracoutlynemanganyi thefightagainstinfectionandpaindevilsclawiharpagophytumprocumbensiarichsourceofantiinflammatoryactivity20112022
AT nomagugugxaba fightagainstinfectionandpaindevilsclawiharpagophytumprocumbensiarichsourceofantiinflammatoryactivity20112022
AT madiracoutlynemanganyi fightagainstinfectionandpaindevilsclawiharpagophytumprocumbensiarichsourceofantiinflammatoryactivity20112022